1. Phosphorothioate-modified antisense oligonucleotides against human telomerase reverse transcriptase sensitize cancer cells to radiotherapy
   Fei Cao et al, 2017, Molecular Medicine Reports CrossRef
2. Targeting human telomerase RNA component using antisense oligonucleotide induces rapid cell death and increases ATO-induced apoptosis in APL cells
   Leila Asghari-Kia et al, 2017, European Journal of Pharmacology CrossRef
3. Inhibition of human telomerase reverse transcriptase in vivo and in vitro for retroviral vector-based antisense oligonucleotide therapy in ovarian cancer
   Z Qi et al, 2016, Cancer Gene Therapy CrossRef